CoChat

Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies

Huttner, N A, Girod, A, Perabo, L, Edbauer, D, Kleinschmidt, J A, Büning, H, Hallek, M · 2003 · Gene Therapy

The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.

Abstract

The high prevalence of human serum antibodies against adeno-associated virus type 2 (AAV) vectors represents a potential limitation for in vivo applications. Consequently, the development of AAV vectors able to escape antibody binding and neutralization is of importance. To identify capsid domains which contain major immunogenic epitopes, six AAV capsid mutants carrying peptide insertions in surface exposed loop regions (I-261, I-381, I-447, I-534, I-573, I-587) were analyzed. Two of these mutants, I-534 and I-573, showed an up to 70% reduced affinity for AAV antibodies as compared to wild-type AAV in the majority of serum samples. In addition, AAV mutant I-587 but not wild-type AAV efficiently transduced cells despite the presence of neutralizing antisera. Taken together, the results show that major neutralizing effects of human AAV antisera might be overcome by the use of AAV capsid mutants.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.gt.3302123

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 45 references

Cited by

See all 126

Metadata

Authors
Huttner, N. A., Girod, A., Perabo, L., Edbauer, D., Kleinschmidt, J. A., Büning, H., & Hallek, M.
Affiliations
  • Ludwig-Maximilians-Universität München (DE)
  • German Cancer Research Center (DE)
  • Helmholtz Munich (DE)
Venue
Gene Therapy
Published
2003-11-17
Volume
10
Issue
26
Pages
2139-2147
ISSN
  • 0969-7128 (ISSN-L)
  • 1476-5462
OpenAlex
W2070754430
Cited by
124
References
46
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 5 · 2022: 12 · 2021: 6 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 5 · 2016: 2 · 2015: 11 · 2014: 8 · 2013: 4 · 2012: 4
FWCI
3.56
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Gene Therapy (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
adeno-associated virus type 2, AAV capsid, capsid mutants, antibody neutralization, human serum antibodies, immunogenic epitopes, antibody affinity, transduction efficiency, adeno-associated virus vectors
MeSH terms
Dependovirus, Antibodies, Viral, Antibody Affinity, Capsid, Genetic Vectors, HeLa Cells, Humans, Immune Sera, Mutation, Transduction, Genetic, Mutagenesis, Insertional

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies. https://app.cochat.ai/papers/10.1038/sj.gt.3302123
The paper
Huttner, N. A., Girod, A., Perabo, L., Edbauer, D., Kleinschmidt, J. A., Büning, H., & Hallek, M. (2003). Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies. Gene Therapy. https://doi.org/10.1038/sj.gt.3302123

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.